FDA issues quarterly list of drugs with potential safety concerns

08/29/2010 | Reuters

Roche Holding's breast cancer drug Herceptin and Sanofi-Aventis' heart drug Multaq are on the FDA's quarterly list of treatments being investigated for possible safety risks. The list also includes Pfizer's antibiotic Cleocin, Merck & Co.'s contraceptive Implanon and Novartis' cancer treatment Afinitor.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Deputy Director, Marketing
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Director of Operations - GBS
Mayo Clinic
MN
Director of Actuarial Services, Government Programs
PacificSource
OR
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC